These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19870643)

  • 1. INFECTIOUS MYXOMATOSIS OF RABBITS : PREPARATION OF ELEMENTARY BODIES AND STUDIES OF SEROLOGICALLY ACTIVE MATERIALS ASSOCIATED WITH THE DISEASE.
    Rivers TM; Ward SM
    J Exp Med; 1937 Jun; 66(1):1-14. PubMed ID: 19870643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INFECTIOUS MYXOMATOSIS OF RABBITS : STUDIES OF A SOLUBLE ANTIGEN ASSOCIATED WITH THE DISEASE.
    Rivers TM; Ward SM; Smadel JE
    J Exp Med; 1939 Jan; 69(1):31-48. PubMed ID: 19870836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : I. PREPARATION OF ELEMENTARY BODIES OF VACCINIA.
    Parker RF; Rivers TM
    J Exp Med; 1935 Jun; 62(1):65-72. PubMed ID: 19870402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies by electron microscopy of thin sections of infectious myxomatosis in rabbits.
    EPSTEIN B; REISSIG M; DE ROBERTIS E
    J Exp Med; 1952 May; 95(5):347-54. PubMed ID: 12981219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor alpha, Shope fibroma growth factor, and vaccinia growth factor can replace myxoma growth factor in the induction of myxomatosis in rabbits.
    Opgenorth A; Nation N; Graham K; McFadden G
    Virology; 1993 Feb; 192(2):701-9. PubMed ID: 8380671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMMUNOLOGICAL AND CHEMICAL INVESTIGATIONS OF VACCINE VIRUS : III. RESPONSE OF RABBITS TO INACTIVE ELEMENTARY BODIES OF VACCINIA AND TO VIRUS-FREE EXTRACTS OF VACCINE VIRUS.
    Parker RF; Rivers TM
    J Exp Med; 1936 Jan; 63(1):69-94. PubMed ID: 19870461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.
    Mossman K; Nation P; Macen J; Garbutt M; Lucas A; McFadden G
    Virology; 1996 Jan; 215(1):17-30. PubMed ID: 8553583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELEMENTARY BODIES OF VACCINIA FROM INFECTED CHORIO-ALLANTOIC MEMBRANES OF DEVELOPING CHICK EMBRYOS.
    Smadel JE; Wall MJ
    J Exp Med; 1937 Aug; 66(3):325-36. PubMed ID: 19870666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits.
    Mossman K; Lee SF; Barry M; Boshkov L; McFadden G
    J Virol; 1996 Jul; 70(7):4394-410. PubMed ID: 8676463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pox on thee! Manipulation of the host immune system by myxoma virus and implications for viral-host co-adaptation.
    Zúñiga MC
    Virus Res; 2002 Sep; 88(1-2):17-33. PubMed ID: 12297325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo inhibition of myxoma virus by treatment with phosphonoacetic acid.
    Goodrich JM; Lee KW; Hinze HC
    Arch Virol; 1981; 70(2):157-64. PubMed ID: 7332492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myxomatosis: the occurrence of antibody to a soluble antigen of myxoma virus in wild rabbits, Oryctolagus cuniculus (L.), in Victoria, Australia.
    Edmonds JW; Shepherd RC; Nolan IF
    J Hyg (Lond); 1978 Oct; 81(2):245-9. PubMed ID: 701788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to myxoma virus.
    Kerr P; McFadden G
    Viral Immunol; 2002; 15(2):229-46. PubMed ID: 12081009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INFECTIOUS MYXOMATOSIS OF RABBITS : II. DEMONSTRATION OF A SECOND SOLUBLE ANTIGEN ASSOCIATED WITH THE DISEASE.
    Smadel JE; Ward SM; Rivers TM
    J Exp Med; 1940 Jul; 72(2):129-38. PubMed ID: 19871012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral skin diseases of the rabbit.
    Meredith AL
    Vet Clin North Am Exot Anim Pract; 2013 Sep; 16(3):705-14. PubMed ID: 24018033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies in the epidemiology of infectious myxomatosis of rabbits. II. Field experiments, August-November 1950, and the first epizootic of myxomatosis in the Riverine Plain of south-eastern Australia.
    MYERS K
    J Hyg (Lond); 1954 Mar; 52(1):47-59. PubMed ID: 13152364
    [No Abstract]   [Full Text] [Related]  

  • 17. Virulence and pathogenesis of the MSW and MSD strains of Californian myxoma virus in European rabbits with genetic resistance to myxomatosis compared to rabbits with no genetic resistance.
    Silvers L; Inglis B; Labudovic A; Janssens PA; van Leeuwen BH; Kerr PJ
    Virology; 2006 Apr; 348(1):72-83. PubMed ID: 16442580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coevolution of host and virus: cellular localization of virus in myxoma virus infection of resistant and susceptible European rabbits.
    Best SM; Collins SV; Kerr PJ
    Virology; 2000 Nov; 277(1):76-91. PubMed ID: 11062038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.
    Cavadini P; Botti G; Barbieri I; Lavazza A; Capucci L
    Vaccine; 2010 Jul; 28(33):5414-20. PubMed ID: 20598407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of myxoma viruses encoding a defective M135R gene from clinical cases of myxomatosis; possible implications for the role of the M135R protein as a virulence factor.
    Belsham GJ; Polacek C; Breum SØ; Larsen LE; Bøtner A
    Virol J; 2010 Jan; 7():7. PubMed ID: 20078890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.